Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner

Journal of Immunology

Volumn 183, Issue 11, 2009, Pages 7471-7477

  Wang, Xiaoyang ^a,b   Stridh, Linnea ^a   Li, Wenli ^a,b   Dean, Justin ^a   Elmgren, Anders ^c   Gan, Liming ^c   Eriksson, Kristina ^d   Hagberg, Henrik ^a,e   Mallard, Carina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ZHENGZHOU UNIVERSITY   (China)

^c ASTRAZENECA R AND D   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 9; KERATINOCYTE DERIVED CHEMOKINE; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE; MYD88 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HISTOPATHOLOGY; KNOCKOUT MOUSE; MICROGLIA; MOUSE; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CASPASE 3; CHEMOKINES; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; POLYMERASE CHAIN REACTION;

EID: 73349083077     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900762     Document Type: Article

References (53)

1. Dammann, O., and A. Leviton. 2004. Inflammatory brain damage in preterm newborns: dry numbers, wet lab, and causal inferences. Early Hum. Dev. 79: 1-15. (Pubitemid 39036744)
2. Duncan, J. R., M. L. Cock, J. P. Scheerlinck, K. T. Westcott, C. McLean, R. Harding, and S. M. Rees. 2002. White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr. Res. 52: 941-949.
3. Svedin, P., I. Kjellmer, A. Welin, S. Blad, and C. Mallard. 2005. Maturational effects of lipopolysaccharide on white-matter injury in fetal sheep. J. Child Neurol. 20: 960-964. (Pubitemid 43299326)
4. Hagberg, H., and C. Mallard. 2005. Effect of inflammation on central nervous system development and vulnerability. Curr. Opin. Neurol. 18: 117-123. (Pubitemid 40477485)
5. Eklind, S., C. Mallard, P. Arvidsson, and H. Hagberg. 2005. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr. Res. 58: 112-116.
6. Eklind, S., C. Mallard, A. L. Leverin, E. Gilland, K. Blomgren, I. Mattsby-Baltzer, and H. Hagberg. 2001. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur. J. Neurosci. 13: 1101-1106.
7. Wang, X., P. Svedin, C. Nie, R. Lapatto, C. Zhu, M. Gustavsson, M. Sandberg, J. O. Karlsson, R. Romero, H. Hagberg, and C. Mallard. 2007. N-Acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury. Ann. Neurol. 61: 263-271.
8. Wang, X., H. Hagberg, C. Nie, C. Zhu, T. Ikeda, and C. Mallard. 2007. Dual role of intrauterine immune challenge on neonatal and adult brain vulnerability to hypoxia-ischemia. J. Neuropathol. Exp. Neurol. 66: 552-561.
9. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
10. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364.
11. Lehnardt, S., L. Massillon, P. Follett, F. E. Jensen, R. Ratan, P. A. Rosenberg, J. J. Volpe, and T. Vartanian. 2003. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA 100: 8514-8519.
12. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
13. Wang, X., H. Hagberg, C. Mallard, C. Zhu, M. Hedtjarn, C. F. Tiger, K. Eriksson, A. Rosen, and B. Jacobsson. 2006. Disruption of interleukin-18, but not interleukin- 1, increases vulnerability to preterm delivery and fetal mortality after intrauterine inflammation. Am. J. Pathol. 169: 967-976.
14. Rice, J. E., 3rd, R. C. Vannucci, and J. B. Brierley. 1981. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9: 131-141. (Pubitemid 11191192)
15. Wang, X., C. Zhu, L. Qiu, H. Hagberg, M. Sandberg, and K. Blomgren. 2003. Activation of ERK1/2 after neonatal rat cerebral hypoxia-ischaemia. J. Neurochem. 86: 351-362. (Pubitemid 36842434)
16. Wang, X., C. Zhu, H. Hagberg, L. Korhonen, M. Sandberg, D. Lindholm, and K. Blomgren. 2004. X-linked inhibitor of apoptosis (XIAP) protein protects against caspase activation and tissue loss after neonatal hypoxia-ischemia. Neurobiol. Dis. 16: 179-189. (Pubitemid 38569809)
17. Gubits, R. M., R. E. Burke, G. Casey-McIntosh, A. Bandele, and F. Munell. 1993. Immediate early gene induction after neonatal hypoxia-ischemia. Brain Res. 18: 228-238. (Pubitemid 23130609)
18. Grafe, M. R. 1994. Developmental changes in the sensitivity of the neonatal rat brain to hypoxic/ischemic injury. Brain Res. 653: 161-166. (Pubitemid 24252834)
19. Wang, X., C. Zhu, J. G. Gerwien, A. Schrattenholz, M. Sandberg, M. Leist, and K. Blomgren. 2004. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J. Neurochem. 91: 900-910. (Pubitemid 39507367)
20. Hedtjarn, M., A. L. Leverin, K. Eriksson, K. Blomgren, C. Mallard, and H. Hagberg. 2002. Interleukin-18 involvement in hypoxic-ischemic brain injury. J. Neurosci. 22: 5910-5919. (Pubitemid 35387635)
21. Hedtjarn, M., C. Mallard, P. Arvidsson, and H. Hagberg. 2005. White matter injury in the immature brain: role of interleukin-18. Neurosci. Lett. 373: 16-20. (Pubitemid 39536213)
22. Wang, X., J. O. Karlsson, C. Zhu, B. A. Bahr, H. Hagberg, and K. Blomgren. 2001. Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia. Biol. Neonate 79: 172-179. (Pubitemid 32247082)
23. Kielian, T., N. K. Phulwani, N. Esen, M. M. Syed, A. C. Haney, K. McCastlain, and J. Johnson. 2007. MyD88-dependent signals are essential for the host immune response in experimental brain abscess. J. Immunol. 178: 4528-4537. (Pubitemid 46492405)
24. Covert, M. W., T. H. Leung, J. E. Gaston, and D. Baltimore. 2005. Achieving stability of lipopolysaccharide-induced NF-κB activation. Science 309: 1854-1857.
25. Hoffmann, A., A. Levchenko, M. L. Scott, and D. Baltimore. 2002. The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298: 1241-1245. (Pubitemid 35285493)
26. Cheng, Y., J. M. Gidday, Q. Yan, A. R. Shah, and D. M. Holtzman. 1997. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann. Neurol. 41: 521-529. (Pubitemid 27169192)
27. Hu, B. R., C. L. Liu, Y. Ouyang, K. Blomgren, and B. K. Siesjo. 2000. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J. Cereb. Blood Flow Metab. 20: 1294-1300.
28. Zhu, C., X. Wang, F. Xu, B. A. Bahr, M. Shibata, Y. Uchiyama, H. Hagberg, and K. Blomgren. 2005. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ. 12: 162-176. (Pubitemid 40220647)
29. Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489. (Pubitemid 27508237)
30. Lehnardt, S., E. Schott, T. Trimbuch, D. Laubisch, C. Krueger, G. Wulczyn, R. Nitsch, and J. R. Weber. 2008. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of Toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 28: 2320-2331.
31. Tang, S. C., T. V. Arumugam, X. Xu, A. Cheng, M. R. Mughal, D. G. Jo, J. D. Lathia, D. A. Siler, S. Chigurupati, X. Ouyang, et al. 2007. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. USA 104: 13798-13803.
32. Koedel, U., U. M. Merbt, C. Schmidt, B. Angele, B. Popp, H. Wagner, H. W. Pfister, and C. J. Kirschning. 2007. Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. Am. J. Pathol. 171: 200-213.
33. Prinz, M., F. Garbe, H. Schmidt, A. Mildner, I. Gutcher, K. Wolter, M. Piesche, R. Schroers, E. Weiss, C. J. Kirschning, et al. 2006. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116: 456-464.
34. Eklind, S., H. Hagberg, X. Wang, K. Savman, A. L. Leverin, M. Hedtjarn, and C. Mallard. 2006. Effect of lipopolysaccharide on global gene expression in the immature rat brain. Pediatr. Res. 60: 161-168.
35. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
36. Esen, N., and T. Kielian. 2006. Central role for MyD88 in the responses of microglia to pathogen-associated molecular patterns. J. Immunol. 176: 6802-6811.
37. Cai, Z., S. Lin, Y. Pang, and P. G. Rhodes. 2004. Brain injury induced by intracerebral injection of interleukin-1βand tumor necrosis factor-α in the neonatal rat. Pediatr. Res. 56: 377-384. (Pubitemid 39128822)
38. Favrais, G., L. Schwendimann, P. Gressens, and V. Lelievre. 2007. Cyclooxygenase-2 mediates the sensitizing effects of systemic IL-1-β on excitotoxic brain lesions in newborn mice. Neurobiol. Dis. 25: 496-505. (Pubitemid 46304239)
39. Xu, H., J. D. Barks, G. P. Schielke, and F. S. Silverstein. 2001. Attenuation of hypoxia-ischemia-induced monocyte chemoattractant protein-1 expression in brain of neonatal mice deficient in interleukin-1 converting enzyme. Brain Res. 90: 57-67. (Pubitemid 32497172)
40. Lazovic, J., A. Basu, H. W. Lin, R. P. Rothstein, J. K. Krady, M. B. Smith, and S. W. Levison. 2005. Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke J. Cerebral Circ. 36: 2226-2231. (Pubitemid 41429251)
41. Nijboer, C. H., C. J. Heijnen, F. Groenendaal, M. J. May, F. van Bel, and A. Kavelaars. 2008. Strong neuroprotection by inhibition of NF-κB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke J. Cerebral Circ. 39: 2129-2137.
42. Nijboer, C. H., C. J. Heijnen, F. Groenendaal, M. J. May, F. van Bel, and A. Kavelaars. 2008. A dual role of the NF-αB pathway in neonatal hypoxicischemic brain damage. Stroke J. Cerebral Circ. 39: 2578-2586.
43. Ubogu, E. E., M. B. Cossoy, and R. M. Ransohoff. 2006. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 27: 48-55. (Pubitemid 43063124)
44. Hanisch, U. K., and H. Kettenmann. 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10: 1387-1394.
45. Hanisch, U. K. 2002. Microglia as a source and target of cytokines. Glia 40: 140-155.
46. Hanisch, U. K., M. Prinz, K. Angstwurm, K. G. Hausler, O. Kann, H. Kettenmann, and J. R. Weber. 2001. The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. Eur. J. Immunol. 31: 2104-2115.
47. Lalancette-Hebert, M., G. Gowing, A. Simard, Y. C. Weng, and J. Kriz. 2007. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27: 2596-2605.
48. Simard, A. R., and S. Rivest. 2007. Neuroprotective effects of resident microglia following acute brain injury. J. Comp. Neurol. 504: 716-729. (Pubitemid 350246584)
49. Cheng, Y., M. Deshmukh, A. D'Costa, J. A. Demaro, J. M. Gidday, A. Shah, Y. Sun, M. F. Jacquin, E. M. Johnson, and D. M. Holtzman. 1998. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 101: 1992-1999. (Pubitemid 28226119)
50. Gustavsson, M., M. F. Anderson, C. Mallard, and H. Hagberg. 2005. Hypoxic preconditioning confers long-term reduction of brain injury and improvement of neurological ability in immature rats. Pediatr. Res. 57: 305-309. (Pubitemid 40165613)
51. Gustavsson, M., M. A. Wilson, C. Mallard, C. Rousset, M. V. Johnston, and H. Hagberg. 2007. Global gene expression in the developing rat brain after hypoxic preconditioning: involvement of apoptotic mechanisms? Pediatr. Res. 61: 444-450.
52. Mallard, C., and H. Hagberg. 2007. Inflammation-induced preconditioning in the immature brain. Semin. Fetal Neonatal. Med. 12: 280-286.
53. McLaughlin, B., K. A. Hartnett, J. A. Erhardt, J. J. Legos, R. F. White, F. C. Barone, and E. Aizenman. 2003. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc. Natl. Acad. Sci. USA 100: 715-720.